Surmodics | SRDX - Los Gastos Financieros De La Deuda





Los Gastos Financieros De La Deuda Cambio Fecha
Abbott USD 42M 2M 2025-12
Align Technology USD 2M 660K 2023-03
Anika Therapeutics 189.44M 1.76M 2025-09
Arrowhead Research USD 22.5M 811K 2025-12
Artivion USD 5.53M 589K 2025-12
Baxter International USD 58M 14M 2025-09
Boston Scientific USD 90M 3M 2025-12
EDAP TMS EUR 49K 8K 2025-09
Edwards Lifesciences USD 38.6M 1.2M 2025-09
Haemonetics USD 7.21M 3.14M 2025-09
Heron Therapeutics USD 600K 100K 2024-12
J&J USD 18M 290M 2025-09
Merit Medical Systems USD 6.36M 390K 2025-12
Mesa Laboratories USD 3.02M 180K 2024-09
Nektar Therapeutics USD 6.02M 420K 2024-09
Option Care Health USD 12.73M 1.41M 2025-12
Stryker USD 157M 46.17B 2025-09
Surmodics USD 884K 5K 2024-09
Trinity Biotech USD 3.33M 50K 2025-09